The products are slated to be manufactured at the Ankleshwar facility and is expected to start contributing meaningfully to the revenue from FY25
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Two-year partnership focused on advocacy, education, and raising awareness of stroke as a global healthcare challenge
The product is expected to start contributing meaningfully to the revenue from FY25
Six engaging sessions focusing on Prevention of Kidney Diseases, Brain Stem Death Declaration, Deceased Donor Management, Prevention of Liver Diseases, Legal Aspects of Organ and Tissue Donation, Eye Donation and Corneal Transplant held as part of the Webinar
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
Health Secretary highlights the need for capacity building programmes for Medical Officers to tackle Non Communicable Diseases at the primary level
Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc
Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022
Subscribe To Our Newsletter & Stay Updated
